Nutex Health Files 8-K on Security Holder Votes & Financials

Ticker: NUTX · Form: 8-K · Filed: Jul 16, 2025 · CIK: 1479681

Sentiment: neutral

Topics: corporate-governance, financial-reporting, sec-filing

Related Tickers: NUTX

TL;DR

Nutex Health filed an 8-K for security holder votes and financials.

AI Summary

On July 14, 2025, Nutex Health, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders and financial statements. The company, formerly known as Clinigence Holdings, Inc. and iGambit, Inc., is incorporated in Delaware and headquartered in Houston, Texas.

Why It Matters

This filing indicates important corporate actions and financial reporting, which are crucial for investors to understand the company's governance and financial health.

Risk Assessment

Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating any immediate operational or financial distress.

Key Numbers

Key Players & Entities

FAQ

What specific matters were submitted to a vote of security holders?

The filing indicates a submission of matters to a vote of security holders, but the specific details of these matters are not provided in the provided text.

What is the significance of the financial statements being filed?

The filing includes financial statements, which are essential for investors to assess the company's financial performance and condition.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on July 14, 2025.

What were Nutex Health, Inc.'s former names?

Nutex Health, Inc. was formerly known as Clinigence Holdings, Inc. and iGambit, Inc.

Where is Nutex Health, Inc.'s principal executive office located?

Nutex Health, Inc.'s principal executive office is located at 6030 S. Rice Ave, Suite C, Houston, Texas 77081.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 16, 2025 regarding Nutex Health, Inc. (NUTX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing